Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Elokdah Mahmoud Hassan
公开号:US20070037802A1
公开(公告)日:2007-02-15
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.